Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

UCB First-Half Earnings Rise 9.6%, Beating Analyst Estimates; Sales Climb
Bloomberg
Monday, August 2, 2010 - 10:10am
tags:
UCB Pharmaceuticals, earnings
Dr Reddy's Seeks Partners to Enter Japan Market This Year, Express Reports
Bloomberg
Monday, August 2, 2010 - 10:09am
tags:
Dr Reddy's, Japan
Activist Directors Drive Up Price for Genzyme
NY Times, NY
Monday, August 2, 2010 - 10:07am
tags:
Genzyme, Sanofi, M&A
NEJM Editorial Raises Questions About Dendreon’s Cancer Vaccine Study: Biotech's Latest Mishaps
Seeking Alpha
Monday, August 2, 2010 - 10:03am
tags:
New England Journal of Medicine, Provenge, Dendreon, prostate cancer
Teva Looks to Latin America for Growth
Seeking Alpha
Sunday, August 1, 2010 - 9:07pm
tags:
Teva Pharmaceuticals, Latin America, Mexico, Brazil
Orexigen Steps Up Pace in Obesity Drug Race
Seeking Alpha
Sunday, August 1, 2010 - 2:47pm
tags:
Orexigen, Arena Pharmaceuticals, Vivus, Contrave, Qnexa
Merck Charts China Expansion With Sinopharm Deal
Seeking Alpha
Sunday, August 1, 2010 - 2:46pm
tags:
Merck, Sinopharm, China, partnerships
WuXi CEO Blames Short-Term Financial Concerns for Merger's Demise
Seeking Alpha
Sunday, August 1, 2010 - 2:35pm
tags:
M&A, Charles River Laboratories, WuXi PharmaTech
Sanofi Prepares Bid for Genzyme as Need to Diversify Portfolio Increases
Seeking Alpha
Sunday, August 1, 2010 - 2:31pm
tags:
Genzyme, M&A, Sanofi
Regeneron Pharmaceuticals: Warming Up or Cooling Off?
Motley Fool
Sunday, August 1, 2010 - 2:30pm
tags:
Regeneron
3 Development-Stage Drugmakers Worth Watching
Motley Fool
Sunday, August 1, 2010 - 2:29pm
tags:
InterMune, Medivation, Exelixis, Bristol-Myers Squibb, GSK, Roche, Seattle Genetics, Regeneron
Geron says FDA will allow embryonic stem cell study; safety concerns caused 11-month delay
Yahoo/AP
Sunday, August 1, 2010 - 2:27pm
tags:
Geron, stem cells, clinical trials, FDA, spinal cord injury
A Faster Pathway to Drug Approvals
Motley Fool
Sunday, August 1, 2010 - 2:26pm
tags:
Europe, FDA, drug approvals, AMA, Eli Lilly, Takeda, Pfizer, Eisai, Epix
Teva: Canadian regulators clear Ratiopharm deal
Yahoo/AP
Sunday, August 1, 2010 - 2:24pm
tags:
Teva Pharmaceuticals, Ratiopharm, M&A
Sanofi-Aventis CEO Plays Cool on Genzyme
WSJ Online
Friday, July 30, 2010 - 11:43am
tags:
Pharma CEOs, Genzyme, M&A, Sanofi, Chris Viehbacher
Merck Ready to Play Let’s Make an (Emerging Markets) Deal
WSJ Online
Friday, July 30, 2010 - 11:42am
tags:
Merck, emerging markets, M&A, Brazil, China, India
Senate Committee OKs Pay-To-Delay Provision
Pharmalot
Friday, July 30, 2010 - 11:26am
tags:
pay-for-delay, generics
Astellas to shutter NY facilities, cut jobs
Fierce Pharma
Friday, July 30, 2010 - 11:24am
tags:
Astellas, layoffs
Amgen: On the Path to a Blockbuster
Motley Fool
Friday, July 30, 2010 - 11:23am
tags:
Prolia, Amgen, osteoporosis
Orexigen's Two-Drug Obesity Pill Cuts Hunger, Cravings, Weight in Study
Bloomberg
Friday, July 30, 2010 - 11:05am
tags:
Orexigen, obesity, Contrave, Vivus, Arena Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.